This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Sukhbinder Singh Klair: Innovator in Pyrrolidine Derivatives
Introduction
Sukhbinder Singh Klair is a notable inventor based in Linton, GB. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrrolidine derivatives. His research focuses on developing compounds that serve as chymase inhibitors, which have potential therapeutic applications.
Latest Patents
Sukhbinder Singh Klair holds a patent for "Pyrrolidine derivatives and their use as chymase inhibitor." This patent describes novel pyrrolidine derivatives that are useful as chymase inhibitors or intermediates for synthesizing active compounds. The formula includes various substituents such as cycloalkyl, substituted or unsubstituted phenyl or naphthyl, and other complex groups. His work in this area is crucial for advancing drug development.
Career Highlights
Sukhbinder Singh Klair is associated with Dainippon Pharmaceutical Company, Limited, where he applies his expertise in medicinal chemistry. His career is marked by a commitment to innovation and the development of new therapeutic agents. With a patent portfolio that includes 1 patent, he continues to contribute to the scientific community.
Collaborations
Throughout his career, Sukhbinder has collaborated with esteemed colleagues such as Fuminori Sato and Buichi Fujitani. These collaborations have enhanced his research and expanded the impact of his work in the pharmaceutical industry.
Conclusion
Sukhbinder Singh Klair is a prominent figure in the field of medicinal chemistry, known for his innovative work on pyrrolidine derivatives. His contributions have the potential to influence future therapeutic developments significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
